The global market value in 2022 was about USD 2.45 billion and is anticipated be driven by the growing demand for blood components for transfusion across the globe. The global apheresis market share is anticipated to grow at a CAGR of 9.2% during the forecast period of 2023-2031 to achieve a value of USD 5.40 billion by 2031.
North America: The largest market for apheresis, driven by factors such as the advanced healthcare infrastructure, high prevalence of chronic diseases, and significant investments in apheresis research and development.
Europe: The second-largest market, with increasing demand for apheresis due to a growing aging population, a supportive regulatory framework, and an expanding healthcare sector.
Asia Pacific: Expected to witness the highest growth rate due to factors such as a rapidly growing population, increasing prevalence of chronic diseases, and growing investments in healthcare infrastructure and research.
Apheresis: Introduction
Apheresis is a medical procedure that involves the separation and removal of specific components from blood, such as plasma, platelets, red blood cells, or white blood cells, while the remaining components are returned to the patient or donor. Apheresis is primarily used to collect specific blood components for transfusion, for the treatment of certain medical conditions, and to remove harmful substances from the blood in patients with specific diseases.Apheresis Market Scenario
The global apheresis market has witnessed significant growth in recent years, driven by factors such as the increasing prevalence of chronic diseases, the growing demand for blood components for transfusion, and advancements in apheresis technology.North America: The largest market for apheresis, driven by factors such as the advanced healthcare infrastructure, high prevalence of chronic diseases, and significant investments in apheresis research and development.
Europe: The second-largest market, with increasing demand for apheresis due to a growing aging population, a supportive regulatory framework, and an expanding healthcare sector.
Asia Pacific: Expected to witness the highest growth rate due to factors such as a rapidly growing population, increasing prevalence of chronic diseases, and growing investments in healthcare infrastructure and research.
Apheresis Market Segmentations
Market Breakup by Product
- Devices
- Disposables
Market Breakup by Technology
- Centrifugation
- Membrane Separation
Market Breakup by Procedure
- Plasmapheresis
- Leukapheresis
- Erythrocytapheresis
- Plateletpheresis
- Others
Market Breakup by Application
- Renal Disease
- Hematological Disease
- Autoimmune Disease
- Neurological Disease
- Others
Market Breakup by End User
- Blood Collection Centers and Blood Component Providers
- Hospitals and Transfusion Centers
- Others
Market Breakup by Region
North America
- United States of America
- Canada
Europe
- United Kingdom
- Germany
- France
- Italy
- Others
Asia Pacific
- China
- Japan
- India
- ASEAN
- Australia
- Others
Latin America
- Brazil
- Argentina
- Mexico
- Others
Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Nigeria
- South Africa
- Others
Key Trends in the Apheresis Market
Some key trends of the market are as follows:- Increasing prevalence of chronic diseases: The rising incidence of chronic diseases, such as cancer, autoimmune diseases, and blood disorders, has led to a growing demand for apheresis procedures, driving market growth
- Growing demand for blood components for transfusion: The increasing need for blood components, such as platelets and plasma, for transfusion in the treatment of various medical conditions has contributed to the growth of the apheresis market
- Advancements in apheresis technology: The development of new apheresis techniques and devices, such as automated and continuous flow systems, has improved the efficiency and safety of apheresis procedures, further driving market growth
Apheresis Market: Competitor Landscape
The report gives an in-depth analysis of the key players involved in the apheresis market, sponsors manufacturing the drugs, and putting them through trials to get FDA approvals. The companies included in the market are as follows:- Nikkiso Co., Ltd
- Asahi Kasei Medical Co. Ltd
- B. Braun Melsungen AG
- Fresenius SE & Co. KGaA
- Terumo Bct, Inc
- Haemonetics Corporation
- Mallinckrodt
- Kaneka Corporation
- Kawasumi Laboratories, Inc
- Miltenyi Biotec
- Infomed
- Toray Medical Co., Ltd
Table of Contents
1 Preface
3 Global Apheresis Market Overview
4 Global Apheresis Market Landscape
5 Global Apheresis Market Dynamics
6 Global Apheresis Market Segmentation
7 North America Apheresis Market
8 Europe Apheresis Market
9 Asia Pacific Apheresis Market
10 Latin America Apheresis Market
11 Middle East and Africa Apheresis Market
12 Patent Analysis
13 Grants Analysis
14 Funding Analysis
15 Partnership and Collaborations Analysis
16 Regulatory Framework
17 Supplier Landscape
18 Global Apheresis Market- Distribution Model (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
21 Payment Methods (Additional Insight)
Companies Mentioned
- Nikkiso Co. Ltd.
- Asahi Kasei Medical Co. Ltd
- B. Braun Melsungen AG
- Fresenius Se & Co. Kgaa
- Terumo Bct, Inc
- Haemonetics Corporation
- Mallinckrodt
- Kaneka Corporation
- Kawasumi Laboratories, Inc.
- Miltenyi Biotec
- Infomed
- Toray Medical Co. Ltd.
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 160 |
| Published | April 2023 |
| Forecast Period | 2023 - 2031 |
| Estimated Market Value ( USD | $ 2.67 Billion |
| Forecasted Market Value ( USD | $ 5.4 Billion |
| Compound Annual Growth Rate | 9.2% |
| Regions Covered | Global |
| No. of Companies Mentioned | 12 |
